A | B | |||||
---|---|---|---|---|---|---|
All patients (n = 18,724) | Asthma only (no COPD) (n = 16,703) | |||||
Mild to moderate | Severe | P value | Mild to moderate | Severe | P value | |
Study population, n (%) | 17,934 (95.8) | 790 (4.2) | <0.001 | 16,142 (96.6) | 561 (3,4) | <0.001 |
Female, n (%) | 11,293 (63.0) | 472 (59.7) | 0.071 | 10,157 (62.9) | 337 (60.1) | 0.169 |
Age at index | 48.8 (19.2) | 56.9 (16.9) | <0.001 | 46.6 (18.6) | 52.3 (16.8) | <0.001 |
Age at death (years) | 78.0 (13.2) | 81.0 (8.6) | 0.042 | 77.2 (15.1) | 81.0 (10.2) | 0.165 |
BMI (kg/m2)a | 27.6 (6.0) | 27.9 (5.8) | 0.274 | 27.6 (6.0) | 28.0 (5.6) | 0.248 |
FEV1% predicted value post bronchodilationb | 83.6 (21.1) | 67.5 (25.9) | <0.001 | 89.7 (15.9) | 80.0 (22.1) | 0.003 |
FVC % predicted value post bronchodilationb | 94.7 (18.6) | 84.3 (21.1) | <0.001 | 97.7 (16.5) | 91.1 (19.8) | 0.043 |
FEV1/FVCb | 0.737 (0.138) | 0.640 (0.175) | <0.001 | 0.777 (0.097) | 0.715 (0.140) | 0.005 |
Eosinophilsc, ×103 cells/μL | 0.32 (0.43) | 0.40 (0.63) | 0.065 | 0.31 (0.44) | 0.37 (0.43) | 0.132 |